Skip to main content
SpringerLink
Log in
Book cover

N-Acetylaspartate pp 145–163Cite as

Defective Myelin Lipid Synthesis as a Pathogenic Mechanism of Canavan Disease

  • Conference paper

Part of the book series: Advances in Experimental Medicine and Biology ((volume 576))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

11. References

  1. L. van Bogaert, I. Bertrand, Sur une idiote familiale avec degenerescence spongieuse de neuraxe (note preliminaire). Acta Neurol. Belg., 12, 572–587 (1949).

    Google Scholar 

  2. G. R. Hogan, E. P. Richardson, Jr., Spongy degeneration of the nervous system (Canavan’s disease). Pediatrics, 35, 284–294 (1965).

    PubMed  CAS  Google Scholar 

  3. H. Pratt, Canavan’s disease and spongiform encephalopathy. Br. Med. J., 4(837), 427 (1972).

    Article  PubMed  CAS  Google Scholar 

  4. M. Adachi, L. Schneck, J. Cara and B. W. Volk, Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan’s disease). A review. Hum. Pathol., 4(3), 331–347 (1973).

    Article  PubMed  CAS  Google Scholar 

  5. E. C. Traeger, I. Rapin, The clinical course of Canavan disease. Pediatr. Neurol., 18(3), 207–212 (1998).

    Article  PubMed  CAS  Google Scholar 

  6. B. J. Zeng, Z. H. Wang, L. A. Ribeiro, P. Leone, R. De Gasperi, S. J. Kim, S. Raghavan, E. Ong, G. M. Pastores and E. H. Kolodny, Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. J. Inherit. Metab Dis., 25(7), 557–570 (2002).

    Article  PubMed  CAS  Google Scholar 

  7. S. Kamoshita, I. Rapin, K. Suzuki and K. Suzuki, Spongy degeneration of the brain. A chemical study of two cases including isolation and characterization of myelin. Neurology, 18(10), 975–985 (1968).

    PubMed  CAS  Google Scholar 

  8. R. Matalon, R. Kaul and K. Michals, Canavan disease: biochemical and molecular studies. J. Inherit. Metab. Dis., 16, 744–752 (1993).

    Article  PubMed  CAS  Google Scholar 

  9. R. Matalon, K. Michals and R. Kaul, Canavan disease: from spongy degeneration to molecular analysis. J Pediatr., 127(4), 511–517 (1995).

    Article  PubMed  CAS  Google Scholar 

  10. R. Matalon, P. L. Rady, K. A. Platt, H. B. Skinner, M. J. Quast, G. A. Campbell, K. Matalon, J. D. Ceci, S. K. Tyring, M. Nehls, S. Surendran, J. Wei, E. L. Ezell and S. Szucs, Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J. Gene Med., 2(3), 165–175 (2000).

    Article  PubMed  CAS  Google Scholar 

  11. S. Surendran, K. M. Matalon, S. Szucs, S. K. Tyring and R. Matalon, Metabolic changes in the knockout mouse for Canavan’s disease: implications for patients with Canavan’s disease. J. Child Neurol., 18(9), 611–615 (2003).

    PubMed  Google Scholar 

  12. S. Surendran, E. L. Ezell, M. J. Quast, J. Wei, S. K. Tyring, K. Michals-Matalon and R. Matalon, Mental retardation and hypotonia seen in the knock out mouse for Canavan disease is not due to succinate semialdehyde dehydrogenase deficiency. Neurosci. Lett., 358(1), 29–32 (2004).

    Article  PubMed  CAS  Google Scholar 

  13. S. Surendran, G. A. Campbell, S. K. Tyring and R. Matalon, Aspartoacylase gene knockout results in severe vacuolation in the white matter and gray matter of the spinal cord in the mouse. Neurobiol. Dis., 18(2), 385–389 (2005).

    Article  PubMed  CAS  Google Scholar 

  14. S. Kamoshita, I. Rapin, K. Suzuki and K. Suzuki, Spongy degeneration of the brain. A chemical study of two cases including isolation and characterization of myelin. Neurology, 18(10), 975–985 (1968).

    PubMed  CAS  Google Scholar 

  15. L. Hagenfeldt, I. Bollgren and N. Venizelos, N-acetylaspartic aciduria due to aspartoacylase deficiency-a new aetiology of childhood leukodystrophy. J. Inherit. Metab. Dis., 10, 135–141 (1987).

    Article  PubMed  CAS  Google Scholar 

  16. H. J. Wittsack, H. Kugel, B. Roth and W. Heindel, Quantitative measurements with localized 1H MR spectroscopy in children with Canavan’s disease. J. Magn Reson. Imaging, 6(6), 889–893 (1996).

    PubMed  CAS  Google Scholar 

  17. N. Aydinli, M. Caliskan, M. Calay and M. Ozmen, Use of localized proton nuclear magnetic resonance spectroscopy in Canavan’s disease. Turk. J. Pediatr., 40(4), 549–557 (1998).

    PubMed  CAS  Google Scholar 

  18. R. Kaul, G. P. Gao, K. Balamurugan and R. Matalon, Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat. Genet., 5(2), 118–123 (1993).

    Article  PubMed  CAS  Google Scholar 

  19. R. Matalon, K. Michals-Matalon, Molecular basis of Canavan disease. Eur. J. Paediatr. Neurol., 2(2), 69–76 (1998).

    Article  PubMed  CAS  Google Scholar 

  20. A. Feigenbaum, R. Moore, J. Clarke, S. Hewson, D. Chitayat, P. N. Ray and T. L. Stockley, Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay. Am. J. Med. Genet. A, 124(2), 142–147 (2004).

    Article  PubMed  Google Scholar 

  21. M. E. Truckenmiller, M. A. Namboodiri, M. J. Brownstein and J. H. Neale, N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J. Neurochem., 45, 1658–1662 (1985).

    Article  PubMed  CAS  Google Scholar 

  22. A. F. D’Adamo, Jr., J. C. Smith and C. Woiler, The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat. J. Neurochem., 20(4), 1275–1278 (1973).

    Article  PubMed  CAS  Google Scholar 

  23. J. R. Moffett, M. A. Namboodiri, C. B. Cangro and J. H. Neale, Immunohistochemical localization of Nacetylaspartate in rat brain. Neuroreport, 2, 131–134 (1991).

    PubMed  CAS  Google Scholar 

  24. J. R. Moffett, M. A. Namboodiri and J. H. Neale, Enhanced carbodiimide fixation for immunohistochemistry: Application to the comparative distributions of N-acetylaspartylglutamate and Nacetylaspartate immunoreactivities in rat brain. J. Histochem. Cytochem., 41, 559–570 (1993).

    PubMed  CAS  Google Scholar 

  25. J. R. Moffett, M. A. Namboodiri, Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J. Neurocytol., 24, 409–433 (1995).

    Article  PubMed  CAS  Google Scholar 

  26. R. Matalon, K. Michals, D. Sebesta, M. Deanching, P. Gashkoff and J. Casanova, Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with canavan disease. Am. J. Med. Genet., 29, 463–471 (1988).

    Article  PubMed  CAS  Google Scholar 

  27. M. H. Baslow, Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem. Int., 40(4), 295–300 (2002).

    Article  PubMed  CAS  Google Scholar 

  28. M. H. Baslow, T. R. Resnik, Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. J. Mol. Neurosci., 9(2), 109–125 (1997).

    Article  PubMed  CAS  Google Scholar 

  29. P. Leone, C. G. Janson, L. Bilaniuk, Z. Wang, F. Sorgi, L. Huang, R. Matalon, R. Kaul, Z. Zeng, A. Freese, S. W. McPhee, E. Mee, M. J. During and L. Bilianuk, Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann. Neurol., 48(1), 27–38 (2000).

    Article  PubMed  CAS  Google Scholar 

  30. B. F. Kirmani, D. M. Jacobowitz and M. A. Namboodiri, Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Brain Res. Dev. Brain Res., 140(1), 105–115 (2003).

    Article  PubMed  CAS  Google Scholar 

  31. A. F. D’Adamo, L. I. Gidez and F. M. Yatsu, Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. Exp. Brain Res., 5, 267–273 (1968).

    Article  PubMed  CAS  Google Scholar 

  32. A. F. D’Adamo, Jr., F. M. Yatsu, Acetate metabolism in the nervous system. N-acetyl-L-aspartic acid and the biosynthesis of brain lipids. J. Neurochem., 13(10), 961–965 (1966).

    Article  PubMed  CAS  Google Scholar 

  33. R. Burri, C. Steffen and N. Herschkowitz, N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev. Neurosci., 13, 403–412 (1991).

    PubMed  CAS  Google Scholar 

  34. G. Chakraborty, P. Mekala, D. Yahya, G. Wu and R. W. Ledeen, Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem., 78(4), 736–745 (2001).

    Article  PubMed  CAS  Google Scholar 

  35. V. Mehta, M. A. Namboodiri, N-acetylaspartate as an acetyl source in the nervous system. Brain Res. Mol. Brain Res., 31(1–2), 151–157 (1995).

    Article  PubMed  CAS  Google Scholar 

  36. B. F. Kirmani, D. M. Jacobowitz, A. T. Kallarakal and M. A. Namboodiri, Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. Brain Res. Mol. Brain Res., 107(2), 176–182 (2002).

    Article  PubMed  CAS  Google Scholar 

  37. A. F. D’Adamo, Jr., L. I. Gidez and F. M. Yatsu, Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. Exp. Brain Res., 5(4), 267–273 (1968).

    Article  PubMed  CAS  Google Scholar 

  38. K. K. Bhakoo, T. J. Craig and P. Styles, Developmental and regional distribution of aspartoacylase in rat brain tissue. J. Neurochem., 79(1), 211–220 (2001).

    Article  PubMed  CAS  Google Scholar 

  39. M. Klugmann, C. W. Symes, B. K. Klaussner, C. B. Leichtlein, T. Serikawa, D. Young and M. J. During, Identification and distribution of aspartoacylase in the postnatal rat brain. Neuroreport, 14(14), 1837–1840 (2003).

    Article  PubMed  CAS  Google Scholar 

  40. C. N. Madhavarao, J. R. Moffett, R. A. Moore, R. E. Viola, M. A. Namboodiri and D. M. Jacobowitz, Immunohistochemical localization of aspartoacylase in the rat central nervous system. J. Comp Neurol., 472(3), 318–329 (2004).

    Article  PubMed  CAS  Google Scholar 

  41. J. M. Lowenstein, Effect of (-)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. J. Biol. Chem., 246(3), 629–632 (1971).

    PubMed  CAS  Google Scholar 

  42. C. N. Madhavarao, P. Arun, J. R. Moffett, S. Szucs, S. Surendran, R. Matalon, J. Garbern, D. Hristova, A. Johnson, W. Jiang and M. A. Namboodiri, Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan’s disease. Proc. Natl. Acad. Sci. U. S. A, 102(14), 5221–5226 (2005).

    Article  PubMed  CAS  Google Scholar 

  43. R. L. Jungas, Fatty acid synthesis in adipose tissue incubated in tritiated water. Biochemistry, 7(10), 3708–3717 (1968).

    Article  PubMed  CAS  Google Scholar 

  44. J. M. Dietschy, D. K. Spady, Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res., 25(13), 1469–1476 (1984).

    PubMed  CAS  Google Scholar 

  45. E. D. Muse, H. Jurevics, A. D. Toews, G. K. Matsushima and P. Morell, Parameters related to lipid metabolism as markers of myelination in mouse brain. J. Neurochem., 76(1), 77–86 (2001).

    Article  PubMed  CAS  Google Scholar 

  46. H. A. Jurevics, P. Morell, Sources of cholesterol for kidney and nerve during development. J. Lipid Res., 35(1), 112–120 (1994).

    PubMed  CAS  Google Scholar 

  47. J. Urenjak, S. R. Williams, D. G. Gadian and M. Noble, Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem., 59, 55–61 (1992).

    Article  PubMed  CAS  Google Scholar 

  48. C. Bjartmar, J. Battistuta, N. Terada, E. Dupree and B. D. Trapp, N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann. Neurol., 51(1), 51–58 (2002).

    Article  PubMed  CAS  Google Scholar 

  49. S. E. Knowles, I. G. Jarrett, O. H. Filsell and F. J. Ballard, Production and utilization of acetate in mammals. Biochem. J., 142(2), 401–411 (1974).

    PubMed  CAS  Google Scholar 

  50. D. W. Pethick, D. B. Lindsay, P. J. Barker and A. J. Northrop, Acetate supply and utilization by the tissues of sheep in vivo. Br. J. Nutr., 46(1), 97–110 (1981).

    Article  PubMed  CAS  Google Scholar 

  51. C. N. Madhavarao, C. Chinopoulos, K. Chandrasekaran and M. A. Namboodiri, Characterization of the Nacetylaspartate biosynthetic enzyme from rat brain. J. Neurochem., 86(4), 824–835 (2003).

    Article  PubMed  CAS  Google Scholar 

  52. M. Yudkoff, D. Nelson, Y. Daikhin and M. Erecinska, Tricarboxylic acid cycle in rat brain synaptosomes. Fluxes and interactions with aspartate aminotransferase and malate/aspartate shuttle. J. Biol. Chem., 269(44), 27414–27420 (1994).

    PubMed  CAS  Google Scholar 

  53. A. Bach, P. Metais, [Fats with short and medium chains. Physiological, biochemical, nutritional, and therapeutic aspects]. Ann. Nutr. Aliment., 24(5), 75–144 (1970).

    PubMed  CAS  Google Scholar 

  54. L. R. Schiller, C. A. Santa Ana, M. S. Sheikh, M. Emmett and J. S. Fordtran, Effect of the time of administration of calcium acetate on phosphorus binding. N. Engl. J. Med., 320(17), 1110–1113 (1989).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD, 20814, USA

    Chikkathur N. Madhavarao

  2. Laboratory of Clinical Science, NIMH, NIH, Bethesda, MD, 20892, USA

    David M. Jacobowitz

Authors
  1. Aryan M. A. Namboodiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John R. Moffett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peethambaran Arun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raji Mathew
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sreela Namboodiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Asha Potti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jeremy Hershfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Batool Kirmani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David M. Jacobowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chikkathur N. Madhavarao
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA

    John R. Moffett  & Aryan M. A. Namboodiri  & 

  2. University of Albany, Albany, NY, 12222, USA

    Suzannah B. Tieman

  3. National Institute of Mental Health, Bethesda, MD, 20814, USA

    Daniel R. Weinberger

  4. McLean Hospital, Belmont, MA, 02178, USA

    Joseph T. Coyle

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Namboodiri, A.M.A. et al. (2006). Defective Myelin Lipid Synthesis as a Pathogenic Mechanism of Canavan Disease. In: Moffett, J.R., Tieman, S.B., Weinberger, D.R., Coyle, J.T., Namboodiri, A.M.A. (eds) N-Acetylaspartate. Advances in Experimental Medicine and Biology, vol 576. Springer, Boston, MA . https://doi.org/10.1007/0-387-30172-0_10

Download citation

Publish with us

Policies and ethics

Search

Navigation